Androgen receptor enhancer amplification in matched patient‐derived xenografts of primary and castrate‐resistant prostate cancer-Reference-Cited by-同舟云学术

Androgen receptor enhancer amplification in matched patient‐derived xenografts of primary and castrate‐resistant prostate cancer

Published:2021-03-29 Issue:2 Volume:254 Page:121-134
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Porter Laura H¹,Bakshi Andrew¹²,Pook David¹³,Clark Ashlee¹,Clouston David⁴,Kourambas John⁵,Goode David L²⁶⁷,Risbridger Gail P¹⁶⁷,Taylor Renea A⁶⁷⁸^ORCID,Lawrence Mitchell G¹⁶⁷^ORCID,

Affiliation:

1. Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology Monash University Clayton VIC Australia

2. Computational Cancer Biology Program Peter MacCallum Cancer Centre Melbourne VIC Australia

3. Medical Oncology, Monash Health Clayton VIC Australia

4. TissuPath Mount Waverley VIC Australia

5. Department of Medicine Monash Health, Casey Hospital Berwick VIC Australia

6. Peter MacCallum Cancer Centre Melbourne VIC Australia

7. Sir Peter MacCallum Department of Oncology University of Melbourne Parkville VIC Australia

8. Monash Partners Comprehensive Cancer Consortium, Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Physiology Monash University Clayton VIC Australia

Funder

Cass Foundation

Movember Foundation

National Health and Medical Research Council

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5652

Reference98 articles.

1. Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation